Total Payments
$16,102
2024 Payments
$3,359
Companies
80
Transactions
842
Medicare Patients
6,960
Medicare Billing
$2.2M
Payment Breakdown by Category
Food & Beverage$16,001 (99.4%)
Education$100.67 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,001 | 836 | 99.4% |
| Education | $100.67 | 6 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,338 | 68 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,309 | 83 | $0 (2024) |
| PFIZER INC. | $937.45 | 64 | $0 (2024) |
| Genentech USA, Inc. | $816.90 | 38 | $0 (2024) |
| Merck Sharp & Dohme LLC | $803.88 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $798.44 | 44 | $0 (2024) |
| Amgen Inc. | $599.41 | 29 | $0 (2023) |
| Incyte Corporation | $570.85 | 29 | $0 (2024) |
| Janssen Biotech, Inc. | $556.71 | 25 | $0 (2024) |
| Eisai Inc. | $532.17 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,359 | 155 | Novartis Pharmaceuticals Corporation ($342.81) |
| 2023 | $3,102 | 149 | AstraZeneca Pharmaceuticals LP ($180.13) |
| 2022 | $2,710 | 138 | E.R. Squibb & Sons, L.L.C. ($277.50) |
| 2021 | $1,006 | 51 | PFIZER INC. ($132.35) |
| 2020 | $489.91 | 27 | Merck Sharp & Dohme Corporation ($69.91) |
| 2019 | $2,268 | 131 | Genentech USA, Inc. ($265.84) |
| 2018 | $1,611 | 101 | PFIZER INC. ($236.40) |
| 2017 | $1,556 | 90 | E.R. Squibb & Sons, L.L.C. ($290.93) |
All Payment Transactions
842 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: Oncology | ||||||
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $6.99 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug), Stivarga, Nubeqa | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/04/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Incyte Corporation | PEMAZYRE (Drug) | Food and Beverage | Cash or cash equivalent | $29.79 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug), TEVIMBRA | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Oncology | ||||||
| 11/25/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/21/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: BioOncology | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Oncology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/12/2024 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $14.08 | General |
| 11/06/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.27 | General |
| 10/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug), Stivarga, Nubeqa | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Oncology | ||||||
| 10/14/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,722 | 49,966 | $2.0M | $430,484 |
| 2022 | 29 | 1,461 | 80,495 | $1.8M | $423,238 |
| 2021 | 37 | 1,892 | 115,850 | $4.0M | $803,144 |
| 2020 | 35 | 1,885 | 74,337 | $1.7M | $559,272 |
Total Patients
6,960
Total Services
320,648
Medicare Billing
$2.2M
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 43 | 7,680 | $523,200 | $141,128 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 424 | 911 | $134,828 | $63,461 | 47.1% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 29 | 3,800 | $276,600 | $62,437 | 22.6% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 13 | 20,820 | $437,220 | $48,549 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 284 | $63,616 | $28,793 | 45.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 31 | 214 | $146,804 | $24,210 | 16.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 313 | 1,362 | $47,670 | $10,321 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 284 | 976 | $18,544 | $8,190 | 44.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 43 | 131 | $39,824 | $7,070 | 17.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 50 | 527 | $55,335 | $6,994 | 12.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $9,947 | $3,985 | 40.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 325 | $30,225 | $3,843 | 12.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 52 | $8,164 | $3,452 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $6,321 | $3,029 | 47.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 105 | $14,805 | $2,842 | 19.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $7,425 | $2,624 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,789 | $2,595 | 38.2% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 22 | 104 | $15,808 | $2,576 | 16.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 33 | $3,795 | $1,301 | 34.3% |
| J1453 | Injection, fosaprepitant, 1 mg | Office | 2023 | 11 | 8,850 | $53,100 | $1,083 | 2.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 18 | $1,584 | $830.10 | 52.4% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 15 | 900 | $109,800 | $743.17 | 0.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 2,516 | $2,516 | $240.91 | 9.6% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 22 | 162 | $1,134 | $131.99 | 11.6% |
| J3490 | Unclassified drugs | Office | 2023 | 28 | 90 | $810.00 | $56.31 | 7.0% |
About Dr. Robert Reilly, DO
Dr. Robert Reilly, DO is a Hematology & Oncology healthcare provider based in Langhorne, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124178819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Reilly, DO has received a total of $16,102 in payments from pharmaceutical and medical device companies, with $3,359 received in 2024. These payments were reported across 842 transactions from 80 companies. The most common payment nature is "Food and Beverage" ($16,001).
As a Medicare-enrolled provider, Reilly has provided services to 6,960 Medicare beneficiaries, totaling 320,648 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Langhorne, PA
- Active Since 01/12/2007
- Last Updated 09/22/2010
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1124178819
Products in Payments
- OPDIVO (Biological) $804.26
- KEYTRUDA (Biological) $755.67
- KISQALI (Drug) $584.56
- Lenvima (Drug) $422.55
- JAKAFI (Drug) $386.42
- IMBRUVICA (Drug) $356.85
- IBRANCE (Drug) $296.38
- ZEJULA (Drug) $280.82
- ELIQUIS (Drug) $277.86
- CALQUENCE (Drug) $260.70
- VERZENIO (Drug) $249.04
- MONJUVI (Drug) $237.71
- Xtandi (Drug) $232.03
- Enhertu (Drug) $227.86
- MEKINIST (Drug) $222.20
- VENCLEXTA (Drug) $200.27
- LIBTAYO (Biological) $198.65
- REBLOZYL (Biological) $185.68
- IMFINZI (Biological) $181.46
- NINLARO (Drug) $179.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Langhorne
Dr. Alexander Ostrovsky, Md, MD
Hematology & Oncology — Payments: $10,478
Hematology & Oncology $10,478
Dr. Ajay Kumar, Md, MD
Hematology & Oncology — Payments: $4,381
Hematology & Oncology $4,381
Dr. Carlin Mclaughlin, Do, DO
Hematology & Oncology — Payments: $2,917
Hematology & Oncology $2,917
Youval Katz, Md, Ms, MD, MS
Hematology & Oncology — Payments: $2,863
Hematology & Oncology $2,863
John Youssef, Md, MD
Hematology & Oncology — Payments: $2,615
Hematology & Oncology $2,615
Sparsha Kukunoor, Md, MD
Hematology & Oncology — Payments: $557.99
Hematology & Oncology $557.99